Skip to main content

Peer Review reports

From: Long-lasting severe anemia following treatment with natalizumab for relapsing–remitting multiple sclerosis: a case report

Original Submission
10 Jan 2024 Submitted Original manuscript
1 Feb 2024 Reviewed Reviewer Report - Adibah Daud
20 Feb 2024 Reviewed Reviewer Report - Razan Hayati Zulkeflee
1 Mar 2024 Author responded Author comments - Lars Henrik Dahl Hamnvik
Resubmission - Version 2
1 Mar 2024 Submitted Manuscript version 2
Publishing
15 Apr 2024 Editorially accepted
13 May 2024 Article published 10.1186/s13256-024-04562-8

You can find further information about peer review here.

Back to article page